Phillip A Sharp Alnylam Pharmaceuticals, Inc. (ALNY) insider trading activity

ALNY Quotes by TradingView

Phillip A Sharp is Director of ALNYLAM PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of ALNY, which is worth approximately $0. The most recent transaction as insider was on Jan 23, 2025, when has been sold 11,250 shares (Common Stock) at a price of $275.0 per share, resulting in proceeds of $3,093,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

PHILLIP A SHARP Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 23 2025
SELL
Open market or private sale
$3,093,750 $275.0 p/Share
11,250 Reduced 100.0%
0 Common Stock
Jan 23 2025
BUY
Exercise of conversion of derivative security
$1,476,112 $131.21 p/Share
11,250 Added 50.0%
11,250 Common Stock
Feb 29 2024
SELL
Open market or private sale
$4,593,300 $153.11 p/Share
30,000 Reduced 100.0%
0 Common Stock
Feb 29 2024
BUY
Exercise of conversion of derivative security
$1,777,500 $59.25 p/Share
30,000 Added 50.0%
30,000 Common Stock
Aug 15 2022
SELL
Open market or private sale
$7,741,743 $229.93 p/Share
33,670 Reduced 100.0%
0 Common Stock
Aug 15 2022
BUY
Exercise of conversion of derivative security
$1,581,817 $46.98 p/Share
33,670 Added 50.0%
33,670 Common Stock
Feb 09 2022
SELL
Open market or private sale
$4,500,000 $150.0 p/Share
30,000 Reduced 100.0%
0 Common Stock
Feb 09 2022
BUY
Exercise of conversion of derivative security
$339,900 $11.33 p/Share
30,000 Added 50.0%
30,000 Common Stock
Dec 07 2020
SELL
Bona fide gift
-
235,633 Reduced 100.0%
0 Common Stock
Nov 25 2020
SELL
Open market or private sale
$3,772,200 $125.74 p/Share
30,000 Reduced 11.29%
235,633 Common Stock
Nov 25 2020
BUY
Exercise of conversion of derivative security
$279,000 $9.3 p/Share
30,000 Added 10.15%
265,633 Common Stock

Also insider at

VIR
Vir Biotechnology, Inc. Healthcare
Director
SYRS
Syros Pharmaceuticals, Inc. Healthcare
Director
PAS

Phillip A Sharp

Director
Cambridge, MA

Track Institutional and Insider Activities on ALNY

Follow ALNYLAM PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALNY shares.

Notify only if

Insider Trading

Get notified when an Alnylam Pharmaceuticals, Inc. insider buys or sells ALNY shares.

Notify only if

News

Receive news related to ALNYLAM PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALNY